Avadel Pharmaceuticals plc Overview

Avadel Pharmaceuticals plc Research & Development

Research & Development expenses for AVDL.

Quarterly R&D Expenses

$27.01M

↑ 610.23% YoY

As of Sep 30, 2025

Annual R&D Expenses (TTM)

$39.89M

↑ 200.38% YoY

Trailing 12 months ending Sep 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin